Intraventricular protein delivery for amyotrophic lateral...

Details Intraventricular protein delivery for amyotrophic lateral... Intraventricular protein delivery for amyotrophic lateral...

A - Human Necessities

61

K

A61K 38/30 (2006.01)

Patent

CA 2636438

Amyotrophic Lateral Sclerosis can be successfully treated using intraventricular delivery of a neurotrophic growth factor, IGF-I . The administration can be performed slowly to achieve maximum effect. Effects are seen on both sides of the blood-brain barrier, making this a delivery means for Amyotrophic Lateral Sclerosis which affects both brain and skeletal muscle.

La sclérose latérale amyotrophique peut être traitée avec succès par administration par voie intraventriculaire d'un facteur de croissance neurotrophique, IGF-1. L'administration peut être réalisée lentement pour obtenir un effet maximal. Les effets sont visibles des deux côtés de la barrière hémato-encéphalique, ce qui fait de ce mode d'administration un moyen d'administration efficace pour le traitement de la sclérose latérale amyotrophique qui affecte à la fois le cerveau et le muscle squelettique.

Affiliated with

Also associated with

Rating

Intraventricular protein delivery for amyotrophic lateral... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intraventricular protein delivery for amyotrophic lateral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraventricular protein delivery for amyotrophic lateral... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1685285